Taiwan Universe BioMedicine Inc.
Selected as a startup company by FINDIT Matchmaking in the past two years
Update：2025/12/03
Industries
Main Industry
Biotechnology
Main Product/Service
Main Product
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up
Founded Year
2023
Unified Business No.
94247033
Status
Active
Number of Employees
0
Total Paid-in
Capital
75,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Dr. Min-Shi Lee has more than 30 years experiences in vaccine research and development including 6 years R&D in USA vaccine company, and several national vaccine development projects of enterovirus, influenza H5N1, H7N9 and seasonal influenza. To strengthen and grow Taiwan’s vaccine business, Dr. Min-Shi Lee’s group has established a start-up company for developing bivalent enterovirus vaccines and seasonal influenza virus-like particle (VLP) vaccines and also expend to more diseases area through this innovative technology platforms.
PhD, Oxford University, UK
MPH, National Taiwan University
Investigator, NHRI, Taiwan (2005~)
Scientist, Aviron/Medimmune (1999~2005)
NIPM (former CDC), Taiwan (1993~1998)
>30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
Built Asia-Pacific Network for Enterovirus Surveillance (APNES)
PhD, Oxford University, UK
MPH, National Taiwan University
Investigator, NHRI, Taiwan (2005~)
Scientist, Aviron/Medimmune (1999~2005)
NIPM (former CDC), Taiwan (1993~1998)
>30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
Built Asia-Pacific Network for Enterovirus Surveillance (APNES)
